Caricamento...
The next generation of novel therapies for the management of relapsed multiple myeloma
The advent of various novel therapies such as immunomodulators and proteasome inhibitors has transformed the treatment paradigm for patients with multiple myeloma (MM). As a result, the overall survival has improved dramatically over the last decade. Despite these advances, MM remains mostly incurab...
Salvato in:
| Pubblicato in: | Future Oncol |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Future Medicine Ltd
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5134360/ https://ncbi.nlm.nih.gov/pubmed/27513456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon-2016-0200 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|